Clicky

Reata Pharmaceuticals, Inc. - Class A(RETA) News

Date Title
Sep 9 Does Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy?
Sep 8 Insider Sell: SVP, Chief Accounting Officer Bhaskar Anand Sells 406 Shares of Reata ...
Sep 7 The Petri Dish: Biogen secures $1.5B loan; Mersana CEO departs after trial failure
Aug 10 Could This $6.5 Billion Acquisition Help Turn Biogen's Business Around?
Aug 9 With an Acquisition on the Way, Is Biogen Stock a Buy?
Apr 28 Q1 2023 PTC Therapeutics Inc Earnings Call